7 proven elements of a successful antibiotic stewardship program

Earlier this year, President Obama announced the Administration's 5-year plan to combat antibiotic resistance, a growing public health threat. » Eye-opening components

Patient groups bothered over diminished safety standards for biosimilars

Patients for Biologics Safety & Access (PBSA) sent a letter to FDA addressing safety concerns about final FDA guidance documents issued for biosimilars. » What PBSA is calling for

Continuing Education

MTM essentials for COPD management: Part 1

This month’s CE activity is part of a CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month’s activity is to assist pharmacists in understanding the pathophysiology and pharmacologic treatment of COPD and to discuss how COPD is similar to and different from other chronic respiratory disorders.

To read and print the article with TEST questions, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.

Announcement: The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. To review your registration page or to register, go to: https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

Sleep study: Suvorexant effective in people with insomnia

Suvorexant (Belsomra) was effective and well-tolerated by women and men with insomnia, according to a new study presented at SLEEP 2015 in Seattle. » Study details

• [BLOG]: 741 drugs in antibiotics pipeline, few first-in-class

•FDA issues biosimilar final guidance

RESOURCES

Latest Clinical News

UBM MEDICA